DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,740.00
-30.00 (-0.52%)
At close: Jun 11, 2025, 3:30 PM KST
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 58.68B KRW in the quarter ending March 31, 2025, a decrease of -8.62%. This brings the company's revenue in the last twelve months to 243.74B, up 5.33% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.
Revenue (ttm)
243.74B
Revenue Growth
+5.33%
P/S Ratio
0.61
Revenue / Employee
620.21M
Employees
393
Market Cap
149.54B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| Kia Corporation | 109.25T |
| KB Financial Group | 14.93T |